Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
Clinical trial NCT01111552 · TERMINATED
Trial details
- NCT number
- NCT01111552
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-29
- Primary completion
- 2011-09-27
- Enrollment
- 237
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.